UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treating cancer in older and oldest old patients

Current pharmaceutical design, 2015-01, Vol.21 (13), p.1699-1705

2015

Volltextzugriff (PDF)

Founder mutations in BRCA1 and BRCA2 genes

Annals of oncology, 2007-06, Vol.18 (suppl-6), p.vi93-vi98

2007

Volltextzugriff (PDF)

6563 POSTER Chromogranine a (CG-A) Plus Vascular Endothelial Growth Factor (VEGF) as Predicting Factors (PF) of Sorafenib (SFB) Treatment of Multifocal Hepatocellular Carcinoma (M-HCC) in Elderly Patients

European journal of cancer (1990), 2011, Vol.47, p.S460-S460

2011

Volltextzugriff (PDF)

Sorafenib (SFB) flat dose (FD) in frail elderly patients (FEPts) with Child–Pugh Advanced Hepatocellular Carcinoma (AHCC): Two year

Journal of geriatric oncology, 2012-10, Vol.3, p.S70-S71

2012

Volltextzugriff (PDF)

Cancer in the older person

Cancer treatment reviews, 2005-08, Vol.31 (5), p.380-402

2005

Volltextzugriff (PDF)

Assessment and treatment of elderly people with cancer: Italian (AIOM–SIGG) onco-geriatric survey results

Journal of geriatric oncology, 2012-10, Vol.3, p.S71-S72

2012

Volltextzugriff (PDF)

A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

British journal of cancer, 2001-05, Vol.84 (9), p.1166-1171

2001

Volltextzugriff (PDF)

4017 Antiangiogenetic drugs in combination with irinotecan (IRI) and capecitabine (XEL) in ACRC elderly patients: first data about safety and efficacy

European journal of cancer supplements, 2009, Vol.7 (2), p.220-220

2009

Volltextzugriff (PDF)

Metronomic (M), capecitabine (C), and oxaliplatin (O) plus bevacizumab (B) as treatment of advanced colorectal cancer (ACRC) in very elderly people (M-COB): Efficacy and safety (E&S) evaluation—A 2-year monitoring

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14086-e14086

2011

Volltextzugriff (PDF)

Metronomic therapy irinotecan (IRI) capecitabine (CAP) plus bevacizumab (BEV) in treatment of advanced colorectal cancer (ACRC) in very elderly people

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3552-3552

2010

Volltextzugriff (PDF)

Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy

Anti-cancer drugs, 1993-08, Vol.4 (4), p.443-446

1993

Volltextzugriff (PDF)

Impact of VEGF and CgA as new predictive tools in management of elderly hormone-refractory prostate cancer (HRPC) patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e16070-e16070

2009

Volltextzugriff (PDF)

Management of breast cancer in the older woman

Cancer control, 2001-09, Vol.8 (5), p.431-441

2001

Volltextzugriff (PDF)

Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.19586-19586

2007

Volltextzugriff (PDF)

Efficacy and safety of a combined treatment schedule with fulvestrant (F) and capecitabine (C) in elderly advanced breast cancer patients

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.12003-12003

2008

Volltextzugriff (PDF)

Efficacy of weekly low-dose chemotherapy in elderly women with advanced ovarian cancer: is there an antiangiogenic effect?

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.13133-13133

2006

Volltextzugriff (PDF)

FLOW CYTOMETRIC DNA ANALYSIS IN PREDICTION OF INTRAVESICAL RECURRENCE FROM HUMAN BLADDER-CANCER

International journal of oncology, 1994-09

1994

Volltextzugriff (PDF)

Tailored vinorelbine-capecitabine treatment in elderly metastatic breast cancer patients. A SICOG phase II study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10556-10556

2006

Volltextzugriff (PDF)

Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.1578-1578

2005

Volltextzugriff (PDF)

Reticulocytes can represent an early indicator of the erythropoietic response to Darbepoetin alfa in the anemia by chemotherapy

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8245-8245

2004

Volltextzugriff (PDF)

Reticulocytes can represent an early indicator of the erythropoietic response to Darbepoetin alfa in the anemia by chemotherapy

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8245-8245

2004

Volltextzugriff (PDF)

Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5- fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9624-9624

2004

Volltextzugriff (PDF)

Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5- fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9624-9624

2004

Volltextzugriff (PDF)

A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4132-4132

2005

Volltextzugriff (PDF)

Transferring scientific evidence to oncological practice: a trial on the impact of three different implementation strategies on antiemetic prescriptions

Supportive care in cancer, 2004-06, Vol.12 (6), p.446-453

Roila, Fausto

2004

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

SpracheItalienisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(101)
Berichte
(1)

Sprache

Englisch
(102)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(41)
Humans
(27)
Oncology
(20)
Aged
(15)
Male
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Female
(11)
Proteins
(11)
Middle Aged
(10)
Adult
(8)
Hematology, Oncology And Palliative Medicine
(8)
Proteomics
(8)
Pharmacology. Drug Treatments
(7)
Tumors
(7)
Antineoplastic Agents - Adverse Effects
(6)
Cell Biology
(6)
Neoplasms - Drug Therapy
(6)
Animals
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treating cancer in older and oldest old patients

Founder mutations in BRCA1 and BRCA2 genes

6563 POSTER Chromogranine a (CG-A) Plus Vascular Endothelial Growth Factor (VEGF) as Predicting Factors (PF) of Sorafenib (SFB) Treatment of Multifocal Hepatocellular Carcinoma (M-HCC) in Elderly Patients

Sorafenib (SFB) flat dose (FD) in frail elderly patients (FEPts) with Child–Pugh Advanced Hepatocellular Carcinoma (AHCC): Two year

Cancer in the older person

Assessment and treatment of elderly people with cancer: Italian (AIOM–SIGG) onco-geriatric survey results

A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

4017 Antiangiogenetic drugs in combination with irinotecan (IRI) and capecitabine (XEL) in ACRC elderly patients: first data about safety and efficacy

Metronomic (M), capecitabine (C), and oxaliplatin (O) plus bevacizumab (B) as treatment of advanced colorectal cancer (ACRC) in very elderly people (M-COB): Efficacy and safety (E&S) evaluation—A 2-year monitoring

Metronomic therapy irinotecan (IRI) capecitabine (CAP) plus bevacizumab (BEV) in treatment of advanced colorectal cancer (ACRC) in very elderly people

Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy

Impact of VEGF and CgA as new predictive tools in management of elderly hormone-refractory prostate cancer (HRPC) patients

Management of breast cancer in the older woman

Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis

Efficacy and safety of a combined treatment schedule with fulvestrant (F) and capecitabine (C) in elderly advanced breast cancer patients

Efficacy of weekly low-dose chemotherapy in elderly women with advanced ovarian cancer: is there an antiangiogenic effect?

FLOW CYTOMETRIC DNA ANALYSIS IN PREDICTION OF INTRAVESICAL RECURRENCE FROM HUMAN BLADDER-CANCER

Tailored vinorelbine-capecitabine treatment in elderly metastatic breast cancer patients. A SICOG phase II study

Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG)

Reticulocytes can represent an early indicator of the erythropoietic response to Darbepoetin alfa in the anemia by chemotherapy

Reticulocytes can represent an early indicator of the erythropoietic response to Darbepoetin alfa in the anemia by chemotherapy

Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5- fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC)

Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5- fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC)

A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers

Transferring scientific evidence to oncological practice: a trial on the impact of three different implementation strategies on antiemetic prescriptions

Aktive Filter

Suchergebnisse filtern